Skip to main content

Advertisement

Table 5 Compilation of the antigen-specific response analysis

From: Differential cellular recognition pattern to M. tuberculosis targets defined by IFN-γ and IL-17 production in blood from TB + patients from Honduras as compared to health care workers: TB and immune responses in patients from Honduras

Antigen Group 1 Group 2 Group 3
  IFN-γ (%) IL-17 (%) IFN-γ (%) IL-17 (%) IFN-γ (%) IL-17 (%)
Rv0447c 10/38 (26) 10/38 (26) 24/81 (30) 17/81 (21) 12/29 (41) 11/29 (38)
Rv2940c 3/38 (8)   8/81 (10)   3/29 (10)  
Rv3347c 5/38 (13)   12/81 (15)   12/29 (41)  
Rv2453c 4/38 (11)   11/81 (14)   9/29 (31)  
Rv1886c 14/38 (37) 10/38 (26) 37/81 (46) 27/81 (33) 15/29 (52) 14/29 (48)
Rv1690 6/38 (16)   18/81 (22)   8/29 (28)  
Rv3019c 8/38 (21) 10/38 (26) 29/81 (36) 37/81 (46) 9/29 (31) 16/29 (55)
Rv2957 7/38 (18) 11/38 (29) 30/81 (37) 33/81 (41) 11/29 (38) 12/29 (41)
Rv1085c 6/38 (16)   11/81 (14)   4/29 (14)  
Rv0066c 3/38 (8)   14/81 (17)   4/29 (14)  
Rv2958c 4/38 (11) 14/38 (37) 10/81 (12) 31/81 (38) 7/29 (24) 13/29 (45)
Rv2962c 3/38 (8) 10/38 (26) 10/81 (12) 32/81 (40) 8/29 (28) 15/29 (28)
Rv1886c 12/25(48) 12/25 (48) 40/65 (62) 47/65 (72) 11/17 (65) 15/17 (88)
Rv3804c 15/25 (60) 15/25 (60) 40/65 (62) 44/65 (68) 12/17 (71) 12/17 (71)
Rv3874 13/20 (65) 8/20 (40) 32/48 (67) 25/48 (52) 13/14 (93) 7/14 (50)
Rv3875 9/20 (45) 8/20 (40) 24/48 (50) 11/48 (23) 6/14 (43) 5/14 (36)
Rv0288 pep 3/11 (27)   3/21 (14)   0/3 (0)  
Rv3804c/Rv1886c 3/11 (27)   3/21 (14)   0/3 (0)  
Rv3875/3874 7/9 (78)   6/21 (29)   0/5 (0)  
Rv0754 3/5 (60) 1/5 (20) 1/17 (6) 5/17 (29) 1/3 (33) 3/3 (100)
Rv0978 2/5 (40) 0/5 (0) 4/17 (24) 5/17 (29) 0/3 (0) 2/3 (66)
Rv1917 2/5 (40) 1/5 (20) 2/17 (12) 7/17 (41) 0/3 (0) 3/3 (100)
Rv0288 1/5 (20) 1/5 (20) 1/17 (6) 6/17 (35) 0/3 (0) 2/3 (66)
  1. Group 1, TB + patients, group 2, TB- other pulmonary diseases, group 3, frequent M.tb exposure, yet clinically healthy.